Intrinsiqs

Is Pacific Biosciences of California, Inc. overvalued?

Pacific Biosciences of California, Inc. (PACB) — key valuation metrics and fundamentals.

No verdict
Price
$1.96
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$612.0M
Dividend yield
0.0%
Return on equity
604.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PACB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.